Synthesis of a Tyr-Tyr Dipeptide Library and Evaluation Against Tumor Cells
Journal:
Medicinal Chemistry
Volume:
14
Page:
709-714
Author(s):
Stanley N.S. Vasconcelos, Juliana M. Sciani, Nicole M. Lisboa and Helio A. Stefani*
Recent Advances In Developing Novel Anti-Cancer Drugs Targeting Tumor Hypoxic and Acidic Microenvironments
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
13
Page:
455-468
Author(s):
Weidong Li and Xueying Sun*
Journey Describing the Cytotoxic Potential of Withanolides: A Patent Review
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
13
Page:
411-421
Author(s):
Hidayat Hussain*, Rene Csuk, Ivan R. Green, Najeeb Ur Rehman, Ghulam Abbas and Wahid Hussain
Association of Metronidazole with Cancer: A Potential Risk Factor or Inconsistent Deductions?
Journal:
Current Drug Metabolism
Volume:
19
Page:
902-909
Author(s):
Muhammad Adil, Waheed Iqbal, Fazal Adnan, Shabnam Wazir, Imran Khan, M. Umar Khayam, Mohammad Amjad Kamal, Shafiq Ahmad, Jawad Ahmed* and Ishaq N. Khan*
A Review on Leukemia and iPSC Technology: Application in Novel Treatment and Future
Journal:
Current Stem Cell Research & Therapy
Volume:
13
Page:
665-675
Author(s):
Amirhosein Maali, Amir Atashi, Sasan Ghaffari, Reza Kouchaki, Fereshteh Abdolmaleki and Mehdi Azad*
Box-Behnken Design of Experiment Assisted Development and Optimization of Bendamustine HCl loaded Hydroxyapatite Nanoparticles
Journal:
Current Drug Delivery
Volume:
15
Page:
1230-1244
Author(s):
Shindu C. Thomas, Tushar Madaan, Zeenat Iqbal and Sushama Talegaonkar*
Signal Transduction through JAK-STAT and NF-κB Regulated Pim-1 Kinase: Novel Target for Anticancer Leads
Journal:
Current Signal Transduction Therapy
Volume:
13
Page:
83-104
Author(s):
Sisir Nandi*, Mohd Salman, Ankita Sharma and Mohit Kumar
Significant Role of MUC1 in Development of Resistance to Currently Existing Anti-cancer Therapeutic Agents
Journal:
Current Cancer Drug Targets
Volume:
18
Page:
737-748
Author(s):
Leila Farahmand, Parnaz Merikhian, Neda Jalili, Behrad Darvishi and Keivan Majidzadeh-A*
p53-Mdm2 Interaction Inhibitors as Novel Nongenotoxic Anticancer Agents
Journal:
Current Cancer Drug Targets
Volume:
18
Page:
749-772
Author(s):
Surendra Kumar Nayak*, Gopal L. Khatik, Rakesh Narang, Vikramdeep Monga and Harish Kumar Chopra
Recent Progress in Clinical Development of Therapeutic Antibodies Targeting Glycan-Binding Proteins
Journal:
Current Drug Targets
Volume:
19
Page:
1491-1497
Author(s):
Qun Zhou*